Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 78, Issue 4, Pages 699-706
Publisher
Wiley
Online
2014-03-06
DOI
10.1111/bcp.12371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
- (2013) Ling Luo et al. ACS Nano
- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
- (2013) Ilse Krebs et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration
- (2013) Adrienne W. Scott et al. CURRENT OPINION IN OPHTHALMOLOGY
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition?
- (2012) David J. Browning et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Novel Targets Against Retinal Angiogenesis in Diabetic Retinopathy
- (2012) Shuang Wang et al. Current Diabetes Reports
- Diverse roles for VEGF-A in the nervous system
- (2012) F. Mackenzie et al. DEVELOPMENT
- Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors
- (2012) Helen A. Mintz-Hittner EARLY HUMAN DEVELOPMENT
- The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease
- (2012) Hebah H. Al-Habboubi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- An Evidence-Based Meta-analysis of Vascular Endothelial Growth Factor Inhibition in Pediatric Retinal Diseases: Part 1. Retinopathy of Prematurity
- (2012) Mihai Mititelu et al. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
- Aflibercept
- (2012) Michael W. Stewart et al. NATURE REVIEWS DRUG DISCOVERY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
- (2012) Usha Chakravarthy et al. OPHTHALMOLOGY
- Novartis takes legal action over trusts' advice to use bevacizumab for wet AMD
- (2012) I. Torjesen BMJ-British Medical Journal
- Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File
- (2011) Ross J. Brechner et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity
- (2011) Tatsuhiko Sato et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development
- (2011) Diane C. Darland et al. DEVELOPMENTAL BIOLOGY
- Treatment-Related Mortality With Bevacizumab in Cancer Patients
- (2011) Vishal Ranpura et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008
- (2010) C Bunce et al. EYE
- Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model
- (2010) Jignesh J. Patel et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) Sanjaykumar Hapani et al. ONCOLOGY
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
- (2009) M. Saint-Geniez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicted biological activity of intravitreal VEGF Trap
- (2008) M W Stewart et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vascular endothelial growth factor in eye disease
- (2008) J.S. Penn et al. PROGRESS IN RETINAL AND EYE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started